British 8.832893
ĠBi 8.824033
otech 0.7344889
Ġpl 5.653212
c 0.0018913309
's 5.682254
Ġcancer 6.290228
Ġdrug 0.77258736
ĠMar 8.425278
im 2.8661382
ast 0.005127
at 0.0062527065
ĠShows 9.707402
ĠPromise 1.0465292
, 5.0406947
ĠBut 2.6568654
ĠFaces 3.4244528
ĠH 2.666437
urd 0.009181821
les 0.041643117
Ġto 4.493641
ĠBecome 4.299528
Ġa 0.7684255
ĠBlock 3.1785703
buster 0.0036936272
Ċ 0.7874594
British 14.306545
ĠBi 0.024432845
otech 0.0031649687
Ġpl 0.21613261
c 0.00014337122
Ġannounced 4.5901537
Ġpromising 3.7643476
Ġresults 0.8222688
Ġfor 1.648105
Ġits 0.4229855
Ġcancer 0.79206544
Ġdrug 0.06717685
, 2.1311917
ĠMar 0.20389222
im 0.00025371904
ast 0.0023659621
at 0.002887442
, 0.61150587
Ġwhich 2.0586314
Ġtargets 4.72634
Ġthe 1.8911902
Ġfast 8.737473
- 0.3221039
growing 0.0493941
Ġmatrix 10.430275
Ġmet 0.30853415
all 0.011791115
op 0.015176161
rotein 0.087239385
ase 0.8931321
Ġ( 1.2020447
M 0.010734049
MP 0.00082969584
) 0.361686
Ġmarket 8.781559
. 0.5017116
ĠThe 1.2323112
Ġdrug 1.5444418
Ġis 1.820979
Ġdesigned 3.3860407
Ġto 0.08505824
Ġinhibit 1.630419
Ġthe 1.0331537
Ġactivity 1.3554691
Ġof 0.013307661
Ġspecific 5.0326967
ĠM 0.7957089
MP 0.0003352268
s 0.70749116
Ġthat 1.9451271
Ġpromote 2.9754596
Ġthe 1.7228029
Ġgrowth 1.3847308
Ġand 1.0022271
Ġspread 0.6642556
Ġof 0.0073951078
Ġcancer 0.770036
Ġcells 1.2579249
. 0.35947004
ĠThe 1.4297613
Ġdrug 1.7744606
Ġis 1.5420554
Ġcurrently 1.1875819
Ġin 0.6624371
ĠPhase 0.67287636
ĠIII 0.7581025
Ġclinical 1.0535792
Ġtrials 0.1674679
, 2.2502189
Ġand 1.0400422
Ġresults 3.7026095
Ġfrom 1.1801175
Ġa 1.7032821
Ġrecent 3.590102
Ġtrial 1.2529119
Ġdemonstrate 6.039713
Ġthe 2.545659
Ġdrug 0.55701786
's 0.648211
Ġpotential 1.4031402
Ġas 1.9846722
Ġa 0.35660145
Ġtherapeutic 3.6625073
Ġoption 1.9330826
Ġfor 0.30199385
Ġcancer 2.8115869
Ġpatients 0.41518328
. 0.19414245
Ċ 1.9973698
Mar 1.9833105
im 0.00040355683
ast 0.010073224
at 0.00043593463
Ġhas 3.3187425
Ġbeen 1.7831271
Ġproven 4.3495755
Ġto 0.4280292
Ġbe 1.2028229
Ġeffective 1.0859053
Ġagainst 1.859394
Ġa 1.9349705
Ġwide 1.6594888
Ġrange 0.3691287
Ġof 0.002555792
Ġcancers 0.9411153
, 0.579162
Ġincluding 0.2547563
Ġpancreat 3.4801478
ic 0.000109035354
Ġcancer 1.7737848
, 0.17211309
Ġcol 1.9773028
ore 0.00077069976
ct 0.00018760514
al 0.00044965209
Ġcancer 0.05580764
, 0.12885691
Ġand 1.3557861
Ġmetast 3.4335163
atic 0.06907026
Ġmelan 1.6881129
oma 0.012428879
. 0.21273033
ĠThe 1.281627
Ġdrug 0.42705452
Ġinhibits 3.624589
Ġthe 0.77080137
Ġactivity 0.46093947
Ġof 0.0102344155
ĠM 0.82787836
MP 0.0004210298
s 1.8098638
, 1.4277462
Ġwhich 0.45484173
Ġplay 2.5578637
Ġcritical 4.2982807
Ġroles 0.015402636
Ġin 0.028327823
Ġmany 4.401574
Ġphysiological 3.0141156
Ġprocesses 0.3757106
, 0.61170137
Ġsuch 1.7959847
Ġas 0.0016537999
Ġtissue 1.7422711
Ġremod 0.79259425
eling 0.06409889
, 0.7612424
Ġwound 2.3866537
Ġhealing 0.19967309
, 0.06412463
Ġand 0.38544586
Ġtumor 1.6432471
Ġinvasion 1.0665362
. 0.5542808
ĠWhen 3.8905137
ĠM 0.8697929
MP 0.00021681878
s 0.23204571
Ġare 0.2912196
Ġover 0.6607444
activated 3.666941
, 0.31961456
Ġas 3.4108438
Ġin 1.0461384
Ġcancer 0.9943512
, 0.5450992
Ġthey 0.48654103
Ġpromote 1.812369
Ġthe 0.96567607
Ġgrowth 1.0392557
Ġand 0.25622007
Ġspread 0.12745588
Ġof 0.0029340659
Ġcancer 0.66641164
Ġcells 0.2653003
Ġby 2.4581423
Ġdegrading 1.5119163
Ġthe 0.69738376
Ġext 1.2169797
race 5.460492e-07
llular 0.00017198599
Ġmatrix 0.02043301
Ġ( 1.6130329
EC 0.034242257
M 0.00021610259
) 1.1632128
Ġsurrounding 2.5961862
Ġthe 1.0543017
Ġtumor 0.48888114
. 0.5993903
Ċ 1.676117
The 1.4074914
ĠPhase 2.5872371
ĠIII 0.14648005
Ġclinical 1.1501694
Ġtrial 0.3082402
Ġconducted 4.094196
Ġby 0.54584295
ĠBritish 0.46390715
ĠBi 0.011211447
otech 0.00029354883
Ġpl 2.7119927
c 0.00021669957
Ġdemonstrated 2.3181043
Ġthat 0.7188825
ĠMar 0.54836595
im 0.0003009416
ast 0.0031894224
at 0.00019726387
Ġcan 3.2742257
Ġsignificantly 1.4642217
Ġimprove 2.1035464
Ġthe 0.96324784
Ġprogression 2.2318347
- 0.09371231
free 0.002152809
Ġsurvival 0.032685358
Ġrate 2.4388952
Ġof 0.6881968
Ġpatients 0.8998989
Ġwith 0.38456473
Ġadvanced 1.2520038
Ġpancreat 0.6275984
ic 8.9960085e-05
Ġcancer 0.04918565
. 0.47831187
ĠIn 2.275985
Ġthe 0.8507519
Ġtrial 0.74060273
, 0.018038308
Ġpatients 1.5104883
Ġwho 2.2144775
Ġreceived 0.5780613
ĠMar 0.4830408
im 0.00089961407
ast 0.0015161327
at 0.00022051518
Ġhad 2.4927254
Ġa 0.3257784
Ġmedian 1.0638157
Ġprogression 0.18644002
- 0.022064045
free 0.0012163299
Ġsurvival 0.0076828315
Ġrate 1.0970293
Ġof 0.036668465
Ġ2 4.056359
. 0.018718323
3 2.3869145
Ġmonths 0.031344235
, 0.24368817
Ġcompared 0.6263763
Ġto 0.21217424
Ġ1 1.1536509
. 0.034630306
6 2.476254
Ġmonths 0.007991656
Ġfor 0.37499413
Ġpatients 0.5316602
Ġwho 0.31284514
Ġreceived 0.2967902
Ġthe 1.0910892
Ġplacebo 0.7004398
. 0.120026305
ĠThe 1.3970364
Ġdrug 1.9761068
Ġshowed 4.139444
Ġsimilar 1.7192641
Ġpromising 3.380961
Ġresults 0.11366907
Ġin 0.6616578
Ġthe 1.6490356
Ġtreatment 0.8573531
Ġof 0.0040883743
Ġother 2.7229578
Ġcancers 1.3390713
Ġas 2.008628
Ġwell 0.0034661954
. 0.33187586
Ċ 0.7634955
However 4.0585976
, 0.0015934401
Ġdespite 2.5810256
ĠMar 2.203065
im 0.001122998
ast 0.0019809091
at 0.0013658915
's 0.018407976
Ġpotential 1.9468658
Ġto 1.9098638
Ġbecome 0.5266093
Ġa 0.056600716
Ġblockbuster 0.14299573
Ġdrug 1.1918344
, 0.17625245
Ġthere 1.8983697
Ġare 0.087901235
Ġsignificant 2.3512318
Ġhurdles 1.031443
Ġthat 1.0109673
ĠBritish 1.9622223
ĠBi 0.0028780564
otech 0.00044583555
Ġpl 0.18145353
c 1.2588937e-05
Ġwill 1.2197232
Ġhave 0.6700427
Ġto 0.001204454
Ġovercome 0.12614888
. 1.7099701
ĠFirstly 4.7036448
, 0.00215914
Ġthe 0.70155746
Ġdrug 0.6961873
's 2.2647927
Ġpatent 2.8496506
Ġprotection 1.1171616
Ġhas 2.0175476
Ġexpired 0.4519732
, 0.50884205
Ġwhich 1.0711175
Ġmeans 0.7816661
Ġthat 0.25187206
Ġthe 2.0096743
Ġdrug 0.78949916
Ġis 1.3929363
Ġnow 1.7493235
Ġavailable 1.4334192
Ġas 1.1598805
Ġa 0.06449063
Ġgeneric 0.26776582
Ġdrug 1.2745817
. 0.823475
ĠThis 1.9784899
Ġwill 1.4680674
Ġmake 2.2571259
Ġit 0.24709591
Ġdifficult 0.7051673
Ġfor 0.12261466
ĠBritish 0.79761815
ĠBi 0.004984241
otech 7.1719274e-05
Ġpl 0.24953593
c 0.0001118973
Ġto 0.015951378
Ġgenerate 2.0019836
Ġsignificant 1.1307153
Ġrevenue 0.7479603
Ġfrom 0.38853464
Ġthe 0.53725505
Ġdrug 0.24556172
. 0.65572864
Ċ 1.4697618
Secondly 0.9072119
, 0.00074105157
Ġthe 1.043643
Ġcompany 1.8852078
Ġwill 1.4866512
Ġneed 1.7590032
Ġto 0.012496957
Ġdemonstrate 3.50922
Ġthe 0.9590541
Ġdrug 0.646551
's 0.0069878916
Ġsafety 1.4890279
Ġand 0.372228
Ġefficacy 0.3641373
Ġthrough 3.8443975
Ġfurther 2.559988
Ġclinical 0.25880185
Ġtrials 0.06063995
. 0.63331383
ĠWhile 4.4669194
Ġthe 0.7428115
Ġresults 2.474417
Ġfrom 0.6357351
Ġthe 0.29232335
ĠPhase 0.37732923
ĠIII 0.03373784
Ġclinical 0.84637237
Ġtrial 0.1425677
Ġare 1.3620347
Ġpromising 0.40632722
, 0.015005761
Ġthey 1.8600868
Ġwill 2.9432452
Ġneed 0.4752693
Ġto 0.0154760005
Ġbe 0.027988859
Ġreplicated 1.4762523
Ġin 0.49096072
Ġlarger 2.0844302
- 2.5608447
scale 0.0072668553
Ġtrials 0.87208617
Ġto 1.9648125
Ġensure 1.767304
Ġthat 1.0536519
Ġthe 0.24787503
Ġdrug 0.23723249
Ġis 0.44437507
Ġsafe 0.52954435
Ġand 0.44438308
Ġeffective 0.110853784
Ġfor 1.4002888
Ġa 1.941547
Ġwider 1.7195233
Ġrange 0.44908917
Ġof 0.0010368965
Ġpatients 0.87712634
. 0.094034426
Ċ 0.43079
Third 1.502763
ly 0.026547842
, 0.003087001
ĠMar 2.4537153
im 0.0015133873
ast 0.0026312687
at 0.0002822221
Ġfaces 3.2984285
Ġcompetition 0.8477787
Ġfrom 0.108654104
Ġother 0.8413844
ĠM 1.1375964
MP 0.00013037559
Ġinhibitors 0.14193243
Ġcurrently 2.9814577
Ġin 0.4928535
Ġdevelopment 0.81751204
. 0.5443444
ĠSeveral 4.760213
Ġother 2.021414
Ġpharmaceutical 2.7554576
Ġcompanies 0.071491756
Ġare 0.6863397
Ġdeveloping 0.7668302
ĠM 0.80574745
MP 7.350647e-05
Ġinhibitors 0.06669013
Ġto 2.125696
Ġtarget 2.2678363
Ġcancer 2.0933642
, 1.2107432
Ġsuch 1.6186767
Ġas 0.0013758601
ĠGl 5.55169
ax 0.009195175
o 0.0072131217
Smith 0.004249682
K 0.007283307
line 0.002147252
Ġpl 0.3823234
c 4.5847235e-05
's 1.2184656
ĠB 3.9788957
MS 2.4052367
- 0.01816443
275 1.4418244
291 0.5583333
Ġand 1.0330914
ĠMillennium 6.4488583
ĠPharmaceutical 0.1360182
s 0.02498001
ĠInc 0.64766026
.' 0.22580677
s 0.0037840286
Ġ( 3.6919177
now 5.022211
ĠT 0.7896058
aked 0.005321732
a 0.00020406157
ĠPharmaceutical 0.03843413
ĠCo 1.010777
. 0.6642129
ĠLtd 0.012782409
.) 0.46783656
ĠPrin 11.679479
om 0.047437448
ast 0.0063975058
at 0.00032526677
. 0.16358094
ĠThis 4.6889157
Ġmeans 2.2499375
Ġthat 0.036357936
ĠBritish 0.57400346
ĠBi 0.005228316
otech 0.000677946
Ġpl 0.029447848
c 0.00011440349
Ġwill 0.22452223
Ġneed 1.1661367
Ġto 0.01005745
Ġwork 3.5388386
Ġhard 0.87460124
Ġto 0.07540388
Ġdifferentiate 2.1481826
ĠMar 1.0367198
im 0.00024072528
ast 0.0017092676
at 9.842577e-05
Ġfrom 0.2742596
Ġits 0.84033805
Ġcompetitors 0.11668267
Ġand 2.3089345
Ġposition 4.6103425
Ġit 1.4640632
Ġas 0.13542782
Ġthe 0.8860123
Ġmost 1.5241917
Ġeffective 0.39846158
ĠM 1.3497695
MP 5.5149267e-05
Ġinhibitor 0.018832868
. 1.2163696
Ċ 0.36266607
British 1.7244784
ĠBi 0.0016197691
otech 0.0004436879
Ġpl 0.04994948
c 8.721922e-05
Ġwill 2.4695022
Ġneed 1.4798808
Ġto 0.014813979
Ġinvest 5.665832
Ġin 2.019998
Ġmarketing 3.5354416
Ġand 0.65199924
Ġresearch 4.1204305
Ġand 0.48469356
Ġdevelopment 0.0020125632
Ġto 0.80071354
Ġensure 1.0543752
Ġthat 0.5191093
ĠMar 0.82600313
im 0.0005584239
ast 0.001203857
at 0.00028913716
Ġbecomes 1.8476264
Ġa 0.117017835
Ġblockbuster 0.80804545
Ġdrug 0.1725003
. 0.17175157
ĠThe 1.1487782
Ġcompany 0.16710103
Ġwill 0.7993856
Ġneed 0.9276774
Ġto 0.014134621
Ġconduct 2.1141734
Ġfurther 0.932558
Ġtrials 3.1708198
Ġto 0.31461227
Ġdemonstrate 0.9269472
Ġthe 0.13796312
Ġdrug 0.19068734
's 0.0009664337
Ġsafety 0.26270235
Ġand 0.051422667
Ġefficacy 0.095373645
Ġand 2.5204248
Ġto 1.7437906
Ġdetermine 3.7378979
Ġthe 0.6141486
Ġoptimal 1.8110458
Ġdose 1.8315885
Ġand 1.5011274
Ġtreatment 1.1680728
Ġfor 6.516438
Ġeach 2.4229548
Ġcancer 1.0537952
Ġtype 0.5498066
. 0.09660185
ĠAdditionally 3.4282286
, 0.0023854964
Ġthe 0.51673305
Ġcompany 0.026825031
Ġwill 0.18566023
Ġneed 0.18974142
Ġto 0.0053819558
Ġdevelop 2.5967493
Ġstrong 4.051868
Ġpartnerships 2.4475996
Ġwith 0.28978837
Ġphysicians 3.755461
, 1.8883495
Ġhospitals 1.9758956
, 0.11844472
Ġand 0.0715285
Ġother 1.7920908
Ġstakeholders 2.787154
Ġto 0.43663406
Ġensure 1.027699
Ġthat 0.20991985
ĠMar 1.0019702
im 0.0010829606
ast 0.0014007501
at 3.2855354e-05
Ġis 0.59328955
Ġwidely 2.4052172
Ġprescribed 1.8949716
Ġand 2.0612416
Ġused 0.898086
Ġin 1.6322737
Ġthe 1.2139074
Ġtreatment 0.46121714
Ġof 0.0075033773
Ġcancer 0.33396298
. 0.41555738
Ċ 0.53651696
Despite 3.4694407
Ġthe 0.23568726
Ġchallenges 0.98359877
, 1.351179
ĠMar 0.88943034
im 0.00046312832
ast 0.0009033114
at 0.00036837524
's 1.9255062
Ġpotential 1.36365
Ġto 0.9797137
Ġbecome 0.29932857
Ġa 0.033483442
Ġblockbuster 0.074274935
Ġdrug 0.11237418
Ġis 1.3046668
Ġsignificant 2.3563137
. 0.3932352
ĠThe 0.9293855
Ġdrug 0.34135956
Ġhas 1.2371831
Ġdemonstrated 2.2725449
Ġpromising 1.3753582
Ġresults 0.093963586
Ġin 0.3188659
ĠPhase 1.9571522
ĠIII 0.026743421
Ġclinical 0.17562076
Ġtrials 0.013587489
Ġand 1.4097638
Ġhas 1.1287467
Ġthe 1.1702678
Ġpotential 0.035228096
Ġto 0.005736664
Ġbecome 1.3313935
Ġa 0.47746262
Ġvaluable 3.6751943
Ġtherapeutic 0.7438211
Ġoption 0.062431246
Ġfor 0.12096629
Ġcancer 0.40696645
Ġpatients 0.013608274
. 0.11025531
ĠBritish 1.7471613
ĠBi 0.0020299433
otech 0.0005789419
Ġpl 0.019875735
c 8.0899285e-05
Ġmust 4.881417
Ġwork 1.8189977
Ġhard 0.16966733
Ġto 0.05278114
Ġovercome 0.9922595
Ġthe 0.1107236
Ġhurdles 1.3673904
Ġand 1.4076556
Ġposition 2.0717576
ĠMar 0.82309884
im 0.00052067416
ast 0.0010528873
at 8.018216e-05
Ġas 0.09687342
Ġthe 0.6890023
Ġmost 1.2086849
Ġeffective 0.114826046
ĠM 0.33969322
MP 8.447461e-05
Ġinhibitor 0.008826914
Ġon 2.010378
Ġthe 0.00056164444
Ġmarket 0.007315368
. 0.12098109
ĠWith 5.2867527
Ġthe 1.1355398
Ġright 0.70883614
Ġinvestment 3.1121225
Ġand 0.5559732
Ġstrategy 3.3508248
, 0.038976815
ĠMar 0.8277808
im 0.0005065991
ast 0.0012838254
at 8.268835e-05
Ġcould 0.7568405
Ġbecome 0.5689862
Ġa 0.2639933
Ġkey 4.8081045
Ġplayer 2.4120772
Ġin 0.026904872
Ġthe 0.09434552
Ġfight 2.8775878
Ġagainst 0.01293939
Ġcancer 0.03847681
. 0.16749856
